Grifols (GIFLF) Enterprise Value Growth (5y) (2015 - 2025)

Grifols (GIFLF) Enterprise Value Growth (5y) (2015 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -22.73%
Dec 31, 2024 -24.10%
Dec 31, 2023 2.21%
Dec 31, 2022 10.46%
Dec 31, 2021 -25.85%
Dec 31, 2020 24.46%
Sep 30, 2020 23.14%
Mar 31, 2020 33.09%
Dec 31, 2019 23.14%
Dec 31, 2018 7.04%
Sep 30, 2018 -2.51%
Jun 30, 2018 -4.61%
Mar 31, 2018 24.83%
Dec 31, 2017 -11.51%
Jun 30, 2017 -14.46%
Mar 31, 2017 76.45%
Dec 31, 2016 -15.00%
Sep 30, 2016 -33.76%
Jun 30, 2016 -2.26%
Mar 31, 2016 -35.21%